Srdjan R. Stankovic - 19 Nov 2021 Form 4 Insider Report for ACADIA PHARMACEUTICALS INC (ACAD)

Role
President
Signature
/s/ Austin D. Kim, Attorney-in-Fact
Issuer symbol
ACAD
Transactions as of
19 Nov 2021
Transactions value $
-$53,285
Form type
4
Filing time
23 Nov 2021, 17:00:24 UTC
Previous filing
19 Oct 2021
Next filing
10 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACAD Common Stock Options Exercise +6.25K +16.42% 44.3K 19 Nov 2021 Direct F1
transaction ACAD Common Stock Sale -$53.3K -2.8K -6.33% $19.01 41.5K 22 Nov 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACAD Restricted Stock Units Options Exercise $0 -6.25K -50% $0.00 6.25K 19 Nov 2021 Common Stock 6.25K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
F3 The restricted stock units vest in four equal annual installments beginning 11/19/2019.